08:41:20 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-02-12 Bokslutskommuniké 2024
2024-08-23 Kvartalsrapport 2024-Q2
2024-06-07 Årsstämma 2024
2024-04-26 Bokslutskommuniké 2023
2023-08-24 Kvartalsrapport 2023-Q2
2023-06-12 Ordinarie utdelning ABTEC 0.00 NOK
2023-06-09 Årsstämma 2023
2023-04-28 Bokslutskommuniké 2022
2022-08-24 Kvartalsrapport 2022-Q2
2022-06-10 Ordinarie utdelning ABTEC 0.00 NOK
2022-06-09 Årsstämma 2022
2022-04-29 Bokslutskommuniké 2021
2021-08-25 Kvartalsrapport 2021-Q2
2021-06-10 Ordinarie utdelning ABTEC 0.00 NOK
2021-06-09 Årsstämma 2021
2021-04-30 Bokslutskommuniké 2020
2020-09-11 Extra Bolagsstämma 2020
2020-08-26 Kvartalsrapport 2020-Q2
2020-06-11 Ordinarie utdelning ABTEC 0.00 NOK
2020-06-10 Årsstämma 2020
2020-04-15 Bokslutskommuniké 2019
2019-08-28 Kvartalsrapport 2019-Q2
2019-06-06 Ordinarie utdelning ABTEC 0.00 NOK
2019-06-05 Årsstämma 2019
2019-04-24 Bokslutskommuniké 2018
2019-01-07 Extra Bolagsstämma 2019
2018-08-22 Kvartalsrapport 2018-Q2
2018-05-30 Årsstämma 2018
2018-02-21 Bokslutskommuniké 2017
2017-08-16 Kvartalsrapport 2017-Q2
2017-06-08 Ordinarie utdelning ABTEC 1.00 NOK
2017-06-07 Årsstämma 2017
2017-02-15 Bokslutskommuniké 2016
2016-11-18 Bonusutdelning ABTEC 1
2016-11-17 Kvartalsrapport 2016-Q3
2016-11-17 Extra Bolagsstämma 2016
2016-08-17 Kvartalsrapport 2016-Q2
2016-06-09 Ordinarie utdelning ABTEC 1.50 NOK
2016-06-08 Årsstämma 2016
2016-05-11 Kvartalsrapport 2016-Q1
2016-02-10 Bokslutskommuniké 2015
2015-11-18 Kvartalsrapport 2015-Q3
2015-08-19 Kvartalsrapport 2015-Q2
2015-06-04 Ordinarie utdelning ABTEC 1.00 NOK
2015-06-03 Årsstämma 2015
2015-05-13 Kvartalsrapport 2015-Q1
2015-02-11 Bokslutskommuniké 2014
2014-11-26 Kvartalsrapport 2014-Q3
2014-08-20 Kvartalsrapport 2014-Q2
2014-06-11 Årsstämma 2014
2014-05-21 Kvartalsrapport 2014-Q1
2014-02-12 Bokslutskommuniké 2013
2013-11-27 Kvartalsrapport 2013-Q3
2013-08-21 Kvartalsrapport 2013-Q2
2013-06-13 Kapitalmarknadsdag 2013
2013-06-12 Ordinarie utdelning
2013-06-11 Årsstämma 2013
2013-05-22 Kvartalsrapport 2013-Q1
2013-02-13 Bokslutskommuniké 2012
2012-11-27 Kvartalsrapport 2012-Q3
2012-08-28 Kvartalsrapport 2012-Q2
2012-06-14 Årsstämma 2012
2012-05-23 Kvartalsrapport 2012-Q1
2012-02-17 Bokslutskommuniké 2011
2011-11-30 Kvartalsrapport 2011-Q3
2011-08-29 Kvartalsrapport 2011-Q2
2011-06-17 Ordinarie utdelning
2011-06-16 Årsstämma 2011
2011-05-30 Kvartalsrapport 2011-Q1
2011-02-18 Bokslutskommuniké 2010

Beskrivning

LandNorge
ListaOAX Equities
SektorHälsovård
IndustriBioteknik
Aqua Bio Technology är ett norskt bolag verksamma inom kosmetikabranschen. Bolaget utvecklar, tillverkar och kommersialiserar ingredienser som används inom ett flertal kosmetiska produkter världen över. Störst verksamhet återfinns inom lösningar för hudvårdsprodukter. Merparten av bolagets produkter säljs på en global marknad via diverse distributörer. Bolaget grundades 2004 och har sitt huvudkontor i Lysaker.
2021-05-25 15:37:33

25.5.2021 15:37:33 CEST | Aqua Bio Technology ASA | Total number of voting rights and capital

Reference is made to the stock exchange announcement of Aqua Bio Technology ("ABT" or the "Company") on 29 April 2021 regarding board approval of new shares in a completed private placement raising gross proceeds of approximately NOK 15 million (the "Private Placement"). In connection with the Private Placement, shareholder Kjeveortoped Espen Dahl AS lent out 605,017 shares in order to arrange for settlement of the new shares to be delivered in the Private Placement.

 

The share capital increase pertaining to the issuance of the new shares to settle the share lending agreement with shareholder Kjeveortoped Espen Dahl AS has today been registered with the Norwegian Register of Business Enterprises (Nw. Foretaksregisteret). The share capital increase pertaining to the remaining 698,690 shares issued in the Private Placement is still pending registration. ABT's new share capital is NOK 47,510,970, divided into 19,004,388 shares, each with a nominal value of NOK 2.50.

 

The new shares issued in the Private Placement will initially be issued on a separate ISIN, and will only be converted to the ordinary ISIN of the Company's shares following approval and publication of a listing prospectus.

 

For further information, please contact Espen Kvale, CEO, telephone +47 9162 8092.

 

* * *

 

Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skin care products. ABT's cosmetics ingredients are highly effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and professional users. ABT's focus on commercialization and development of natural ingredients and natural skin care products has been, and will continue to be, an important part of the Company's strategy going forward. ABT is listed on the Euronext Expand market of the Oslo Stock Exchange.

 

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Disclosure regulation

This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.

Contacts

About Aqua Bio Technology ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.